A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2b Study of Ustekinumab, a Human Monoclonal Antibody to Il-12/23p40, in Patients with Moderately to Severely Active Crohnʼs Disease: Results through Week 36 from the CERTIFI Trial: 2011 ACG Presidential Poster
Feagan, Brian, Gasink, C., Gao, L., Blank, M., Johanns, J., Guzzo, C., Sands, B., Hanauer, Stephen, Targan, S., Rutgeerts, P., Ghosh, S., de Villiers, W., Panaccione, R., Greenberg, G., Schreiber, S.,Volume:
106
Journal:
American Journal of Gastroenterology
DOI:
10.14309/00000434-201110002-01227
Date:
October, 2011
File:
PDF, 130 KB
2011